This study is a meta-analysis. We conducted a systematic literature research of international databases, including PubMed, Medline, Web of Science and EMBASE updated in November 2019 by the MeSH heading and/or additional terms to obtain relevant studies. The search terms are included in the manuscript, and all other relevant data is available within the manuscript and its Supporting Information files.

1. Introduction {#sec005}
===============

Dysmenorrhea is the most common gynaecological disorder worldwide, with a prevalence ranging from 50% to 90% according to different countries \[[@pone.0231201.ref001]--[@pone.0231201.ref004]\]. The pelvic or lower abdominal pain is one of the most common symptoms of dysmenorrhea, which usually lasts for three days from the beginning of menstruation. Dysmenorrhea is classified as primary or secondary \[[@pone.0231201.ref005]\]. Primary dysmenorrhea (PD) refers to painful menses or cramps in the lower abdomen before and/or during menstruation without an identifiable organic pathology \[[@pone.0231201.ref006]\]. In contrast, secondary dysmenorrhea refers to menstrual pain resulting from anatomic and/or evident pelvic pathology, such as endometriosis \[[@pone.0231201.ref007]\]. The discomfort brought about by dymenorrhea has negatively affected women's quality of life and their performance in everyday activities. In addition, the prevalence of dysmenorrhea causes heavy medical burden, such as serious health costs \[[@pone.0231201.ref008]\]. Therefore, dysmenorrhea is an urgent public health problem. Nevertheless, about more than 10% of adolescent girls have severe dysmenorrhea, which is the main reason for school and work absenteeism among the adolescent girls \[[@pone.0231201.ref009]\]. However, only a few women seek medical help for this disorder.

Despite the preceding evidence on the prevalence of dysmenorrhea, factors influencing dysmenorrhea over the reproductive life span are not fully understood. In spite of that, hitherto the condition of dysmenorrhea correlates with a number of factors, such as family history of dysmenorrhea, age of menarche onset, caffeine consumption, dietary habits, exercise, cigarette smoking, and some psychological or gynaecological factors \[[@pone.0231201.ref010]\].

Cigarette smoking has been reported in literature as one of the modifiable risk factors for dysmenorrhea. Although women who smoke reported a range of more adverse reproductive outcomes than their non-smoking counterparts, the relationship between smoking and dysmenorrhea is still heterogeneous \[[@pone.0231201.ref011], [@pone.0231201.ref012]\]. That is, some studies found that smokers were more likely to experience dysmenorrhea than non-smokers, whereas other studies reported that smokers were less likely to experience dysmenorrhea than non-smokers, and another study showed that smoking had no effect on dysmenorrhea. For instance, a study conducted in Turkey reported that smokers had a 1.6-fold higher risk of dysmenorrhea than non-smokers \[[@pone.0231201.ref013]\]. This was consistent with an earlier study, which found that women smokers experienced more severe dysmenorrhea, whose degree varied with the number of cigarettes smoked every day \[[@pone.0231201.ref014]\]. Furthermore, Parazzini et al. reported that the risk of dysmenorrhea increased with the duration of smoking and the number of cigarettes smoked every day \[[@pone.0231201.ref015]\]. In contrast, Andersch et al. reported that smokers had significantly less dysmenorrhea than non-smokers \[[@pone.0231201.ref016]\]. In addition, other three studies (two conducted in Turkey and one conducted in Japan) did not find an association between smoking and dysmenorrhea among women \[[@pone.0231201.ref017]--[@pone.0231201.ref019]\].

In this regard, the aim of this study was to quantitatively synthesize the previous findings on the association between cigarette smoking and dysmenorrhea and give further suggestions on interventions for dysmenorrhea.

2. Methods {#sec006}
==========

2.1 Search strategy {#sec007}
-------------------

This meta-analysis was conducted in accordance with the guidelines for observation study protocols (Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines). A systematic search for literature was conducted in the electronic databases of PubMed, Medline, Web of Science, and EMBASE to locate related studies, published not later than November 2019, using the following keywords: "smoking" or "cigarette smoking" or "tobacco" or "nicotine" or "smoke" or "risk factors" in combination with "dysmenorrhea" or "menstruation pain" or "menstruation disorder" or "painful menstruation" or "menstrual painful" or "menstrual dysfunction". Besides, reference lists of eligible studies were searched manually for relevant studies.

2.2 Study selection {#sec008}
-------------------

Studies were considered eligible for inclusion in this meta-analysis if they fulfilled the following inclusion criteria: (a) observational studies published in English, which evaluated the main outcome as the relationship between cigarette smoking and dysmenorrhea, or the influencing factors of dysmenorrhea including cigarette smoking; (b) studies assessed the existence of dysmenorrhea in the smoking and non-smoking groups; and (c) studies presented the sample sizes, number of cases, and odds ratios (ORs) with 95% confidence intervals (CIs). The exclusion criteria of studies were as follows: (a) reviews, studies not on humans, abstracts, and comments; (b) studies on subjects experiencing passive smoking; (c) studies with inadequate information for this meta-analysis; and (d) duplicates of already included studies.

2.3 Data extraction {#sec009}
-------------------

Two authors (Lu-Lu-Qin, Zhao Hu) independently selected eligible studies by screening the titles, abstracts and full texts according to the eligibility criteria. Any discrepancies on the selected studies were resolved by consensus with another author (Bang-An Luo), who reviewed again the different selections and made decisions or agreements based on the eligibility criteria. Then, the following data were extracted from all the studies which met the eligibility criteria: (a) name of first author; (b) publication year; (c) location of the study; (d) sample size; (e) study design; (f) age; (g) type of dysmenorrhea; (h) prevalence of dysmenorrhea; (i) definition of exposure; and (j) outcome. The main variables for assessing the relationship between cigarette smoking and dysmenorrhea were as follows: (a) number of smokers (current and ever); (b) number of females who smoked cigarettes and had dysmenorrhea; (c) number of non-smokers; and (d) number of females who did not smoke and had dysmenorrhea. Extracted data were recorded in standardized tables and confirmed by two investigators separately (Lulu Qin, Zhao Hu).

2.4 Quality assessment {#sec010}
----------------------

The methodological quality of cross-sectional studies was assessed using the tool, the Agency for Healthcare Research and Quality (AHRQ). Studies assessed using this tool are classified as high quality (if they scored 8--11), moderate quality (if they scored 4--7) or low quality (if they scored 0--3). The methodological quality of cohort or case-control studies was assessed using the New-Ottawa Scale (NOS). Studies assessed using the NOS are classified as high quality (if they scored 7--9), moderate quality (if they scored 4--6) or low quality (if they scored 0--3).

2.5 Statistical analysis {#sec011}
------------------------

The ORs together with their corresponding 95% CIs were calculated using the Mantel-Haenszel procedure for the comparisons of dichotomous outcomes between the smoking and non-smoking groups. The heterogeneity among the results of the included studies was evaluated using the *I*^2^ statistic tests. A random-effects model was chosen to calculate the pooled ORs, when there was substantially moderate or high heterogeneity among the included studies. Besides, sensitivity analysis was performed by excluding one study at a time in order to assess the consistency of the pooled estimate of the ORs. Also, the possibility of publication bias was assessed using a funnel plot and the Begg's and Egger's tests (significance level, *p*\<0.05). Furthermore, subgroup analysis was conducted to explore potential heterogeneity according to study design, study location, type of dysmenorrhea and study quality. Only two studies reported the number of cigarettes smoked; thus, we did not analyse the dose-response association between the degree of smoking exposure and dysmenorrhea due to insufficient data. Most statistical analyses were performed in RevMan Software (Version 5.3, Cochrane Collaboration, London, UK). The publication bias test and subgroup analysis were conducted in STATA version 12.0 (StataCorp, College Station, TX).

3. Results {#sec012}
==========

3.1 Study selection {#sec013}
-------------------

The search strategy yielded a total of 3,671 studies, of which 24 were selected as eligible for this meta-analysis following a rigorous screening process ([Fig 1](#pone.0231201.g001){ref-type="fig"}).

![Flow chart of literature search and study selection.](pone.0231201.g001){#pone.0231201.g001}

3.2 Study characteristics {#sec014}
-------------------------

Characteristics of the 24 eligible studies are displayed in [Table 1](#pone.0231201.t001){ref-type="table"}. Among these studies, the diversity of participants' characteristics was considerable. Altogether, these studies investigated 27,091 female participants, among whom 11,731 (43.3%) had dysmenorrhea. In addition, among the 24 eligible studies, there were 4 case-control studies, 2 cohort studies and 18 cross-sectional studies. Moreover, 10 studies were conducted in Europe, 9 in Asia, 3 in North America and 2 in Oceania. The sample sizes of the eligible studies ranged from 258 to 9,067; while age of the participants varied between 15 and 59 years. Considering the individual eligible studies, the prevalence of dysmenorrhea varied between 20.1% and 91.8%. Also, 8 studies investigated cigarette smoking and the risk of primary dysmenorrhea, whereas others explored cigarette smoking and the risk of nonspecific dysmenorrhea. Many of these studies defined smokers as smoking at least one cigarette per day or they described the current smoking status of the participants, while few did not provide a clear definition. Furthermore, some studies defined dysmenorrhea as cramps or abdominal pain or backache one day before and/or the first day of menstruation, while other studies considered dysmenorrhea to be an activity-limiting pain that requires medication. Almost all studies used a self-administered questionnaire to measure the outcomes of dysmenorrhea with respect to smoking status. Additionally, 2 case-control studies and 2 prospective cohort studies were of high quality, whereas other 2 case-control studies were of medium quality according to the assessment tool of NOS ([S1](#pone.0231201.s008){ref-type="supplementary-material"} and [S2](#pone.0231201.s009){ref-type="supplementary-material"} Tables). Also, among the 18 cross-sectional studies, 5 studies were of high quality, 10 studies were of medium quality, and 3 studies were of low quality, following the evaluation with the AHRQ tool ([S3 Table](#pone.0231201.s010){ref-type="supplementary-material"}).

10.1371/journal.pone.0231201.t001

###### Characteristics of the eligible studies for this meta-analysis.

![](pone.0231201.t001){#pone.0231201.t001g}

  Author and year                                        Location of study   Study design      Sample size   Age(years)[\*](#t001fn001){ref-type="table-fn"}   Type of dysmenorrhea   Prevalence of dysmenorrhea (%)   Definition of smoking                  Definition of dysmenorrhea                           Methodological quality(score)
  ------------------------------------------------------ ------------------- ----------------- ------------- ------------------------------------------------- ---------------------- -------------------------------- -------------------------------------- ---------------------------------------------------- -------------------------------
  Wood C(1979)\[[@pone.0231201.ref020]\]                 Australia           Cross-sectional   699           15--59                                            Not specified          45.7                             Never/former/current smoker            Any pain                                             Low(3)
  Teperi J(1989)\[[@pone.0231201.ref021]\]               Finland             Cross-sectional   3370          12--19                                            Not specified          75.5                             No/occasionally/daily smoking          Any pain                                             Medium(4)
  Sundell G(1990)\[[@pone.0231201.ref014]\]              Sweden              Cross-sectional   489           19--24                                            Primary                67.0                             NA                                     Cramps                                               High(8)
  Parazzini F(1994)\[[@pone.0231201.ref015]\]            Italy               Case-control      251           15--44                                            Primary                41.4                             NA                                     Pelvic complaints                                    High(7)
  Charlton A(1996)\[[@pone.0231201.ref022]\]             England             Cross-sectional   2181          16--17                                            Not specified          56.4                             Never/sometime/regular smoking         Any pain                                             Medium(4)
  Kritz-Silverstein D(1999)\[[@pone.0231201.ref023]\]    USA                 Cross-sectional   2912          18--49                                            Not specified          25.1                             Smoked at least 1 cigarettes per day   Cramps                                               High(9)
  Strinić T(2003)\[[@pone.0231201.ref024]\]              Croatia             Cross-sectional   297           11--18                                            Primary                55.2                             Current smoker                         Any pain                                             Medium(4)
  Weissman(2004)\[[@pone.0231201.ref025]\]               USA                 Prospective       404           19--46                                            Primary                76.0                             Current smoker                         Menstrual cramps                                     High(7)
  Burnett MA(2005)\[[@pone.0231201.ref026]\]             Canada              Cross-sectional   1546          ≥18                                               Primary                65.7                             NA                                     Any pain                                             Low(3)
  Patel V(2006)\[[@pone.0231201.ref027]\]                India               Cross-sectional   2262          18--45                                            Not specified          54.7                             NA                                     Cramps/abdominal/backache pain†                      Medium(7)
  László KD(2009)\[[@pone.0231201.ref028]\]              Hungary             Cross-sectional   821           37.2±9.4                                          Not specified          20.1                             Never/former/current smoker            Limiting activity                                    Medium(6)
  Ozerdogan N(2009)\[[@pone.0231201.ref013]\]            Turkey              Cross-sectional   857           17--32                                            Not specified          55.5                             Smoked at least 1 cigarettes per day   Cramps/abdominal /backache pain†                     High(8)
  Unsal A(2010)\[[@pone.0231201.ref018]\]                Turkey              Cross-sectional   623           17--30                                            Not specified          72.7                             Smoked at least 1 cigarettes per day   Abdominal/groin/ lumbar pain                         Medium(5)
  Wong LP(2010)                                          Malaysia            Cross-sectional   1092          15.2±1.4                                          Not specified          74.5                             NA                                     Any pain                                             Medium(5)
  Grandi G(2012)\[[@pone.0231201.ref029]\]               Italy               Cross-sectional   408           22.9±3.0                                          Not specified          84.1                             NA                                     Any pain                                             Medium(5)
  Gagua T(2012)\[[@pone.0231201.ref012]\]                Georgia             Case-control      431           16.0±1.4                                          Primary                52.1                             NA                                     Any pain                                             Medium(5)
  Ju H(2014)\[[@pone.0231201.ref030]\]                   Australia           Prospective       9067          22--27                                            Not specified          25.0                             Never/former/current smoker            Any pain                                             High(7)
  Sahin S(2014)\[[@pone.0231201.ref031]\]                Turkey              Cross-sectional   520           17--25                                            Not specified          69.0                             Smoked at least 1 cigarettes per day   Abdomen/thighs /lower back pain                      High(8)
  Ibrahim NK(2015)\[[@pone.0231201.ref032]\]             Saudi Arabia        Cross-sectional   435           21.4±1.4                                          Not specified          60.9                             NA                                     two or more days of menstrual pain during bleeding   Medium(4)
  Pejčić A(2016)\[[@pone.0231201.ref033]\]               Serbia              Case-control      288           18--29                                            Not specified          84.4                             Smoked at least 1 cigarettes per day   Limiting activity/require medication                 Medium(5)
  Tomás-Rodríguez MI(2017)\[[@pone.0231201.ref034]\]     Spain               Cross-sectional   306           18--30                                            Primary                91.8                             personal history of smoking            Limiting activity                                    Medium(4)
  Abu Helwa HA(2018)\[[@pone.0231201.ref035]\]           Palestine           Cross-sectional   956           19.7±1.5                                          Not specified          85.1                             Current smoker                         Suprapubic/flank/back/thigh pain                     High(8)
  Fernández-Martínez E(2018)\[[@pone.0231201.ref011]\]   Spain               Cross-sectional   258           18--45                                            Not specified          74.8                             NA                                     Any pain                                             Low(3)
  Orhan C(2018)\[[@pone.0231201.ref036]\]                Turkey              Case-control      471           19--22                                            Primary                87.3                             Smoking habit                          painful menstruation in the last 3 months            High(7)

\*data are presented as range or mean±SD; NA: not available

3.3 Smoking and risk of dysmenorrhea {#sec015}
------------------------------------

The relationship between cigarette smoking and dysmenorrhea among females is shown in [Fig 2](#pone.0231201.g002){ref-type="fig"}. Using random-effects model, the results of this meta-analysis showed that, smokers were 1.45 times more likely to develop dysmenorrhea than non-smokers (OR = 1.45, 95% CI: 1.30--1.61). This result was associated with medium heterogeneity (*I*^2^ = 41.0%, *p* = 0.02). Moreover, individuals classified as currently smoking were 1.50 times more likely to develop dysmenorrhea than those who were classified as never smoking (OR = 1.50, 95% CI: 1.33--1.70) and, again, medium heterogeneity was associated with this result (*I*^2^ = 48.0%, *p* = 0.005). Also, being a former smoker was 1.31 times more likely to develop dysmenorrhea than being a never smoker (OR = 1.31, 95% CI: 1.18--1.46), and no heterogeneity was associated with this result (*I*^2^ = 0%, *p* = 0.59). The results are shown in [Fig 3](#pone.0231201.g003){ref-type="fig"} and [Fig 4](#pone.0231201.g004){ref-type="fig"}.

![The association between smoking and dysmenorrhea.](pone.0231201.g002){#pone.0231201.g002}

![The association between current smoking and dysmenorrhea.](pone.0231201.g003){#pone.0231201.g003}

![The association between former smoking and dysmenorrhea.](pone.0231201.g004){#pone.0231201.g004}

3.4 Subgroup and sensitivity analyses {#sec016}
-------------------------------------

The results of sensitivity analysis indicated that inclusion and exclusion of Wood\`s study \[[@pone.0231201.ref020]\] significantly affected the magnitude of the heterogeneity associated with the pooled OR. That is, after excluding this study, the pooled OR was reduced but still significant (OR = 1.39, 95% CI: 1.26--1.54), and with reduced heterogeneity (*I*^*2*^ = 28%). Besides, the pooled results were still significant after excluding one study at a time.

Furthermore, results of subgroup analyses are shown in [Table 2](#pone.0231201.t002){ref-type="table"}. As regards prospective cohort studies, the pooled OR (OR = 1.35, 95% CI: 1. 09--1.67) was lower than that of case-control studies (OR = 2.03, 95% CI: 1.15--3.57) or cross-sectional studies (OR = 1.43, 95% CI: 1.26--1.62) ([S1 Fig](#pone.0231201.s002){ref-type="supplementary-material"}). Comparable pooled ORs were observed among studies conducted in Europe (OR = 1.45, 95% CI: 1.17--1.78), Asia (OR = 1.47, 95% CI: 1.19--1.81), North America (OR = 1.34, 95% CI: 1.12--1.61) and Oceania (OR = 1.64, 1.00--2.68) ([S2 Fig](#pone.0231201.s003){ref-type="supplementary-material"})

10.1371/journal.pone.0231201.t002

###### Pooled ORs and heterogeneity in subgroup analyses.

![](pone.0231201.t002){#pone.0231201.t002g}

  Variables                      No.studies   OR(95% CI)         *I*^2^%   P for heteogeneity
  ------------------------------ ------------ ------------------ --------- --------------------
  Study design                                                             
      Cross-sectional            18           1.43 (1.26,1.62)   41.8      0.033
      Case-control               4            2.03 (1.15,3.57)   37.3      0.188
      Cohort                     2            1.35 (1.09,1.67)   13.4      0.283
  Location of study                                                        
      Asia                       9            1.47 (1.19,1.81)   0.0       0.470
      Europe                     10           1.45 (1.17,1.78)   51.5      0.029
      North American             3            1.34 (1.12,1.61)   26.6      0.256
      Oceania                    2            1.64 (1.00,2.68)   89.0      0.003
  Type of dysmenorrhea                                                     
      Primary                    8            1.56 (1.31,1.86)   0.0       0.686
      Not specific               16           1.41 (1.24,1.61)   52.8      0.007
  Study methodological quality                                             
      High                       9            1.34 (1.23,1.45)   0.0       0.485
      Medium                     12           1.45 (1.19,1.77)   35.2      0.109
      Low                        3            1.36 (0.81,2.28)   83.2      0.003

Considering type of dysmenorrhea, smoking increased the risk of primary dysmenorrhea by 56% among the females (OR = 1.56, 95% CI: 1.31--1.86) ([S3 Fig](#pone.0231201.s004){ref-type="supplementary-material"}). The pooled OR of studies with high methodological quality (OR = 1.34, 95% CI: 1.23--1.45) was lower than that of studies with medium methodological quality (OR = 1.45, 95% CI: 1.19--1.77) and those with low methodological quality (OR = 1.36, 95% CI: 0.81--2.28) ([S4 Fig](#pone.0231201.s005){ref-type="supplementary-material"}).

3.5 Publication bias {#sec017}
--------------------

According to the results of the Begg's test (*z* = 1.66; *p* = 0.097) and Egger's test (*t* = 1.97, *p* = 0.061), there was no significant publication bias. However, the fact that the preceding results were closer to being significant, there might be moderate or non-obvious publication bias as shown by the funnel plot ([S5](#pone.0231201.s006){ref-type="supplementary-material"} and [S6](#pone.0231201.s007){ref-type="supplementary-material"} Figs).

4. Discussion {#sec018}
=============

According to the results of this meta-analysis, there is strong evidence that cigarette smoking is significantly related to an increased risk of dysmenorrhea among women of reproductive age (OR = 1.45, 95% CI: 1.30--1.61). This precise estimation of smoking as a risk factor for dysmenorrhea offers a new approach for prevention of dysmenorrhea among women of reproductive age. There are two previous meta-analyses on the association between cigarette smoking and dysmenorrhea \[[@pone.0231201.ref034], [@pone.0231201.ref035]\]. However, to the best of our knowledge, this is the first meta-analysis to synthesize evidence on the relationship between smoking (including current and former smoking) and dysmenorrhea, using the most comprehensive available evidence in literature. For example, unlike in this study, in the study conducted by Latthe et al \[[@pone.0231201.ref034]\], the number of included studies was limited, and the publication bias was clear. Besides, heterogeneity, subgroup and sensitivity analyses were not reported. Also, in the study by Jenabi et al \[[@pone.0231201.ref037]\], only the relationship between current smoking and dysmenorrhea among females was studied, for which subgroup and sensitivity analyses were lacking to explore potential heterogeneity. Thus, this meta-analysis represents the best available evidence on the consistency and strength of the association between smoking and dysmenorrhea.

Low heterogeneity and no significant publication bias were observed in this meta-analysis, indicating that the results of this study are relatively reliable and scientific. Nevertheless, sensitivity and subgroup analyses were performed to explore potential sources of heterogeneity. Therefore, the results suggested that the study conducted by Wood et al \[[@pone.0231201.ref020]\] was significantly responsible for a considerable amount of the heterogeneity. Subgroup analyses also reported an association between smoking and dysmenorrhea for all the defined stratifications.

Furthermore, results of this meta-analysis implied that the prevalence of dysmenorrhea among smokers was higher than that among non-smokers. This is in agreement with the assertion that smokers might experience more menstrual problems, such as prolonged periods, which have been related to dysmenorrhea \[[@pone.0231201.ref016]\]. In this regard, some studies have suggested that nicotine, a dominant substance in tobacco, could cause vasoconstriction, which may lead to myometrial contraction for the reason of resultant hypoxia \[[@pone.0231201.ref038]\]. Besides, the vasoconstriction leads to dysmenorrhea by decreasing the endometrial blood flow. Also, other studies have shown that nicotine could result in reduced endometrial blood flow, which is common in women with dysmenorrhea \[[@pone.0231201.ref039]\]. Referring to a prospective cohort study conducted in China, females who were exposed to high levels of second-hand smoke were at an increased risk of developing dysmenorrhea than those who were exposed to low levels of second-hand smoke, and that study attributed this phenomenon to the reason of decreasing endometrial blood flow, and resultant hypoxia \[[@pone.0231201.ref040]\]. Moreover, smoking may have a direct impact on the endocrine control of menstruation, as it is regularly related to some menstrual disorders, for example, prolonged periods \[[@pone.0231201.ref015]\], antiestrogenic extraovarian \[[@pone.0231201.ref041]\] and ovarian atrophy \[[@pone.0231201.ref042]\], which have been related to dysmenorrhea. Also, a previous study reported that quitting smoking could help women with dysmenorrhea by relieving symptoms \[[@pone.0231201.ref030]\]. Additionally, dysmenorrhea is thought to be caused by the release of prostaglandins in the menstrual fluid, which produces uterine contractions and pain. Therefore, although smoking is related to dysmenorrhea, more future research is needed to confirm this relationship.

Nonetheless, the findings of this meta-analysis provide a strong evidence that both former and current smoking may make women vulnerable to repeated and painful menstrual pain (dysmenorrhea) throughout their reproductive age. Thus, considering that smoking is a potentially modifiable factor associated with dysmenorrhea, it could serve as an important element in interventions aimed at reducing the prevalence of dysmenorrhea. Therefore, as most women are unaware about the association between smoking and dysmenorrhea, health education on this topic is an effective way to increase their awareness on this association, which may deter their smoking behaviour, and other intervention measures targeted at tobacco cessation might be useful in decreasing the prevalence of dysmenorrhea.

There are some limitations related to the findings of this study.

First, a significantly large proportion of the eligible studies used in this meta-analysis consisted of cross-sectional studies; hence causal connection of smoking to dysmenorrhea cannot be established in this meta-analysis.

Second, more high-quality studies are needed in the future, for this present meta-analysis used few high-quality studies, which may exaggerate the association between smoking and dysmenorrhea.

Third, moderate heterogeneity was observed when estimating the association between smoking and dysmenorrhea, which might affect the accuracy of the estimation. However, although study design and place of study might be sources of the heterogeneity, other factors that may also contribute to the heterogeneity were not explored due to inconsistent reporting of these in the eligible studies. For example, there was lack of uniformity in the diagnosis of dysmenorrhea (see [Table 1](#pone.0231201.t001){ref-type="table"}), and there was no consensus on the definition of smoking, that is, the eligible studies divided females into former/current/never smokers, or smokers/non-smokers. Thus, the definition of dysmenorrhea relied on the subjective reporting of symptoms, which could underestimate or overestimate the prevalence of dysmenorrhea. In the same vein, subgroup analysis with respect to biological aspects could not be conducted due to limited data, for example, dose-response of smoking exposure was reported in only 2 eligible studies. Therefore, future studies need to report the foregoing factors consistently when examining the relationship between smoking and dysmenorrhea.

Lastly, factors which might be confounders for analysing the relationship between smoking and dysmenorrhea, such as age, race, perception of pain, BMI, family history of dysmenorrhea, age of menarche onset, and duration of dysmenorrhea were not considered when investigating the relationship between smoking and dysmenorrhea in the eligible studies. Therefore, future studies should consider these preceding factors when investigating the association between smoking and dysmenorrhea.

5. Conclusions {#sec019}
==============

Dysmenorrhea has been an important public health problem and has a significant negative impact on the affected females. The evidence from this meta-analysis indicated a significant association between cigarette smoking (both current and former smoking) and dysmenorrhea. Therefore, the adverse effects of smoking provide further support for dysmenorrhea prevention plans and emphasize on the need for health intervention programs for females in the future.
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